Tianshui Zhongxing Bio-technology Co Stock

Tianshui Zhongxing Bio-technology Co FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Tianshui Zhongxing Bio-technology Co (002772.SZ) as of Aug 26, 2026 is 194.77 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 247.83 % — a change of -21.41% (lower).

FCF Conversion

194.77 %

YoY

-21.41%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Tianshui Zhongxing Bio-technology Co is 2026 194.77 % . FCF Conversion Rate (FCF/EBITDA) of Tianshui Zhongxing Bio-technology Co was 2025 247.83 % . It decreases by -21.41% lower compared to the previous year.

The Tianshui Zhongxing Bio-technology Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2017
-207.17 CNY
Jan 1, 2018
-375.25 CNY
Jan 1, 2019
-445.18 CNY
Jan 1, 2020
5.08 CNY
Jan 1, 2021
-1,273.75 CNY
Jan 1, 2022
156.51 CNY
Jan 1, 2023
247.83 CNY
Jan 1, 2024
194.77 CNY
The Tianshui Zhongxing Bio-technology Co FCF Conversion history
YEARFCF ConversionYoY
194.77 %-21.41%
247.83 %+58.34%
156.51 %-112.29%
-1,273.75 %-25,176.86%
5.08 %-101.14%
-445.18 %+18.64%
-375.25 %+81.13%
-207.17 %+33.37%
-155.33 %-849.78%
20.72 %-190.10%
-22.99 %—
Access this data via the Eulerpool API
Get Free API Key

Tianshui Zhongxing Bio-technology Co Stock analysis

What does Tianshui Zhongxing Bio-technology Co do? Tianshui Zhongxing Bio-technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tianshui Zhongxing Bio-technology Co stock

FCF Conversion Rate (FCF/EBITDA) of Tianshui Zhongxing Bio-technology Co is 194.77 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Tianshui Zhongxing Bio-technology Co changed from 247.83 % to 194.77 %, representing a -21.41% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Tianshui Zhongxing Bio-technology Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Tianshui Zhongxing Bio-technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — Tianshui Zhongxing Bio-technology Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Tianshui Zhongxing Bio-technology Co